---
title: "Vivoryon Therapeutics NV to Present at World Congress of Nephrology"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/271742260.md"
datetime: "2026-01-07T06:00:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/271742260.md)
  - [en](https://longbridge.com/en/news/271742260.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/271742260.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/271742260.md) | [English](https://longbridge.com/en/news/271742260.md)


# Vivoryon Therapeutics NV to Present at World Congress of Nephrology

Vivoryon Therapeutics N.V., a clinical stage biotechnology company focused on developing small molecule medicines for kidney diseases, will participate in the World Congress of Nephrology (WCN) in Yokohama, Japan, from March 28-31, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivoryon Therapeutics NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001157972-en) on January 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

## 相關資訊與研究

- [Martinrea International (TSE:MRE) Insider Francesco Barbara Purchases 12,333 Shares](https://longbridge.com/zh-HK/news/281708648.md)
- [Claude Subscriptions Will No Longer Cover Usage On 'Third-Party Tools'—Anthropic Cuts OpenClaw Access Amid Surging AI Demand](https://longbridge.com/zh-HK/news/281705754.md)
- [BCCL halts Dhanbad mining after agitation; operations stalled since April 2](https://longbridge.com/zh-HK/news/281708938.md)
- [Tencent expands OpenClaw suite with enterprise tool amid China’s ‘lobster’ craze](https://longbridge.com/zh-HK/news/281708942.md)
- [Prestige Estates launches township in Hyderabad, GDV pegged at ₹9,500 cr](https://longbridge.com/zh-HK/news/281699337.md)